Baker Bros. Advisors Lp - Insider Trading & Ownership

Entity
Company
Location
860 Washington Street, 3 Rd Floor, New York, NY
Summary
The estimated value of insider holdings of Baker Bros. Advisors Lp is at least $7.51B dollars as of April 2, 2025. Baker Bros. Advisors Lp is the Director of BeiGene, Ltd. and owns shares of BeiGene, Ltd. (ONC) stock worth about $2.1B. Baker Bros. Advisors Lp is the Director, 10%+ Owner of INCYTE CORP and owns shares of INCYTE CORP (INCY) stock worth about $1.72B. Baker Bros. Advisors Lp is the Director of MADRIGAL PHARMACEUTICALS, INC. and owns shares of MADRIGAL PHARMACEUTICALS, INC. (MDGL) stock worth about $1.15B. Baker Bros. Advisors Lp is the Director, 10%+ Owner of ACADIA PHARMACEUTICALS INC and owns shares of ACADIA PHARMACEUTICALS INC (ACAD) stock worth about $668M. Baker Bros. Advisors Lp is the Director of Kymera Therapeutics, Inc. and owns shares of Kymera Therapeutics, Inc. (KYMR) stock worth about $648M. Baker Bros. Advisors Lp is the Director, 10%+ Owner of BICYCLE THERAPEUTICS PLC and owns shares of BICYCLE THERAPEUTICS PLC (BCYC) stock worth about $536M. Baker Bros. Advisors Lp is the Director of TScan Therapeutics, Inc. and owns shares of TScan Therapeutics, Inc. (TCRX) stock worth about $308M. Baker Bros. Advisors Lp is the Director, 10%+ Owner of Replimune Group, Inc. and owns shares of Replimune Group, Inc. (REPL) stock worth about $126M. Baker Bros. Advisors Lp is the Director of Kiniksa Pharmaceuticals International, plc and owns shares of Kiniksa Pharmaceuticals International, plc (KNSA) stock worth about $68.6M. Baker Bros. Advisors Lp is the Director of Immunocore Holdings plc and owns shares of Immunocore Holdings plc (IMCR) stock worth about $63.4M. Baker Bros. Advisors Lp is the Director, 10%+ Owner of Prelude Therapeutics Inc and owns shares of Prelude Therapeutics Inc (PRLD) stock worth about $56.6M. Baker Bros. Advisors Lp is the 10%+ Owner of Entrada Therapeutics, Inc. and owns shares of Entrada Therapeutics, Inc. (TRDA) stock worth about $45.8M. Baker Bros. Advisors Lp is the 10%+ Owner of KALA BIO, Inc. and owns shares of KALA BIO, Inc. (KALA) stock worth about $6.98M. Baker Bros. Advisors Lp is the Director, 10%+ Owner of IGM Biosciences, Inc. and owns shares of IGM Biosciences, Inc. (IGMS) stock worth about $4.63M. Baker Bros. Advisors Lp is the Former 10% Owner of Atreca, Inc. and owns shares of Atreca, Inc. stock worth about $1.2M. Baker Bros. Advisors Lp is the Director, Former 10% Owner of Neurogene Inc. and owns shares of Neurogene Inc. (NGNE) stock worth about $287K. Baker Bros. Advisors Lp is the Director of vTv Therapeutics Inc. and owns shares of vTv Therapeutics Inc. (VTVT) stock worth about $11.6K.
All Insider Reports
All Insider Reports

Ownership of Baker Bros. Advisors Lp

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ONC, BEIGF BeiGene, Ltd. Director $2.1B -$385M -15.5% Feb 28, 2025
INCY INCYTE CORP Director, 10%+ Owner $1.72B Mar 31, 2025
MDGL MADRIGAL PHARMACEUTICALS, INC. Director $1.15B Jun 25, 2024
ACAD ACADIA PHARMACEUTICALS INC Director, 10%+ Owner $668M May 29, 2024
KYMR Kymera Therapeutics, Inc. Director $648M +$106M +19.5% Aug 20, 2024
BCYC BICYCLE THERAPEUTICS PLC Director, 10%+ Owner $536M +$21.2M +4.13% Jan 2, 2025
TCRX TScan Therapeutics, Inc. Director $308M Jun 12, 2024
REPL Replimune Group, Inc. Director, 10%+ Owner $126M Mar 5, 2025
KNSA Kiniksa Pharmaceuticals International, plc Director $68.6M Oct 4, 2024
IMCR Immunocore Holdings plc Director $63.4M +$24M +60.9% Mar 17, 2025
PRLD Prelude Therapeutics Inc Director, 10%+ Owner $56.6M Jun 14, 2024
TRDA Entrada Therapeutics, Inc. 10%+ Owner $45.8M +$50M Jun 25, 2024
KALA KALA BIO, Inc. 10%+ Owner $6.98M +$2M +40.2% Dec 30, 2024
IGMS IGM Biosciences, Inc. Director, 10%+ Owner $4.63M Mar 31, 2025
BCEL Atreca, Inc. Former 10% Owner $1.2M Oct 19, 2023
NGNE Neurogene Inc. Director, Former 10% Owner $287K Dec 18, 2023
VTVT vTv Therapeutics Inc. Director $11.6K Jun 25, 2024
SYRE Spyre Therapeutics, Inc. Director Jun 8, 2021
BLCM BELLICUM PHARMACEUTICALS, INC 10%+ Owner Nov 22, 2023
DBVT DBV Technologies S.A. Director, 10%+ Owner Mar 27, 2025
KOD Kodiak Sciences Inc. Director, 10%+ Owner Jun 28, 2024
SGEN Seagen Inc. Director, Former 10% Owner Dec 14, 2023
SERA SERA PROGNOSTICS, INC. 10%+ Owner Feb 12, 2025
TLIS Talis Biomedical Corp Director, 10%+ Owner Jun 9, 2023

Insider Transactions Reported by Baker Bros. Advisors Lp:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.